Probing a polar cluster in the retinal binding pocket of bacteriorhodopsin by a chemical design approach

PLoS One. 2012;7(8):e42447. doi: 10.1371/journal.pone.0042447. Epub 2012 Aug 3.

Abstract

Bacteriorhodopsin has a polar cluster of amino acids surrounding the retinal molecule, which is responsible for light harvesting to fuel proton pumping. From our previous studies, we have shown that threonine 90 is the pivotal amino acid in this polar cluster, both functionally and structurally. In an attempt to perform a phenotype rescue, we have chemically designed a retinal analogue molecule to compensate the drastic effects of the T90A mutation in bacteriorhodopsin. This analogue substitutes the methyl group at position C(13) of the retinal hydrocarbon chain by and ethyl group (20-methyl retinal). We have analyzed the effect of reconstituting the wild-type and the T90A mutant apoproteins with all-trans-retinal and its 20-methyl derivative (hereafter, 13-ethyl retinal). Biophysical characterization indicates that recovering the steric interaction between the residue 90 and retinal, eases the accommodation of the chromophore, however it is not enough for a complete phenotype rescue. The characterization of these chemically engineered chromoproteins provides further insight into the role of the hydrogen bond network and the steric interactions involving the retinal binding pocket in bacteriorhodopsin and other microbial sensory rhodopsins.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptation, Ocular
  • Aspartic Acid / metabolism
  • Bacteriorhodopsins / chemistry
  • Bacteriorhodopsins / metabolism*
  • Binding Sites
  • Biochemistry / methods*
  • Biological Transport
  • Halobacterium salinarum / metabolism
  • Models, Molecular
  • Mutant Proteins / metabolism
  • Protein Denaturation
  • Protein Stability
  • Retinaldehyde / chemical synthesis
  • Retinaldehyde / chemistry
  • Retinaldehyde / metabolism*
  • Temperature

Substances

  • Mutant Proteins
  • Aspartic Acid
  • Bacteriorhodopsins
  • Retinaldehyde

Grants and funding

The authors want to thank the following sources of funding: the Spanish Ministry of Science and Innovation (BES-2004-5542 to RS-V, BFU2009-08758/BMC to EP, SAF2010-21385 to AP-M, SAF2010-17935-FEDER to ARdL), Xunta de Galicia (Grant 08CSA052383PR from DXI+D+i; Consolidación 2006/15 from DXPCTSUG; INBIOMED; Parga Pondal Contract to MD), and European Commission (Marie Curie Action PIOF-GA-2009-237120 to AP-M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.